应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INMB INmune Bio Inc
休市中 08-23 16:00:00 EDT
6.95
+0.50
+7.75%
盘后
6.95
+0.00
0.00%
18:51 EDT
最高
6.99
最低
6.42
成交量
18.39万
今开
6.47
昨收
6.45
日振幅
8.84%
总市值
1.37亿
流通市值
9,317万
总股本
1,978万
成交额
125.92万
换手率
1.37%
流通股本
1,341万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-阿迪生物科学公司、塔吉特公司、伟世通公司
Reuters · 08-22
美国研究综述-阿迪生物科学公司、塔吉特公司、伟世通公司
Inmune Bio Inc.盘中异动 快速下挫5.29%
自选股智能写手 · 08-21
Inmune Bio Inc.盘中异动 快速下挫5.29%
Inmune Bio Inc.盘中异动 急速拉升5.09%报7.22美元
自选股智能写手 · 08-16
Inmune Bio Inc.盘中异动 急速拉升5.09%报7.22美元
Inmune Bio Inc.盘中异动 快速下跌5.01%报6.63美元
自选股智能写手 · 08-15
Inmune Bio Inc.盘中异动 快速下跌5.01%报6.63美元
Inmune Bio Inc.2024财年第二财季实现净利润-9.75百万美元,同比减少50.00%
自选股智能写手 · 08-11
Inmune Bio Inc.2024财年第二财季实现净利润-9.75百万美元,同比减少50.00%
Inmune Bio Inc.盘中异动 临近午盘股价大涨5.11%报7.41美元
自选股智能写手 · 08-08
Inmune Bio Inc.盘中异动 临近午盘股价大涨5.11%报7.41美元
Inmune Bio Inc.盘中异动 早盘股价大跌7.59%报7.55美元
自选股智能写手 · 08-05
Inmune Bio Inc.盘中异动 早盘股价大跌7.59%报7.55美元
Inmune Bio Inc.盘中异动 早盘股价大涨5.18%报8.32美元
自选股智能写手 · 08-02
Inmune Bio Inc.盘中异动 早盘股价大涨5.18%报8.32美元
INmune Bio Inc 预计每股亏损63美分 - 财报前瞻
Reuters · 07-31
INmune Bio Inc 预计每股亏损63美分 - 财报前瞻
Inmune Bio Inc.盘中异动 股价大跌5.03%
自选股智能写手 · 07-30
Inmune Bio Inc.盘中异动 股价大跌5.03%
INmune Bio Inc.宣布了新的第1阶段研究数据证明了Xpro™对调节阿尔茨海默病患者突触蛋白具有剂量依赖性影响。
智通财经 · 07-29
INmune Bio Inc.宣布了新的第1阶段研究数据证明了Xpro™对调节阿尔茨海默病患者突触蛋白具有剂量依赖性影响。
Inmune Bio Inc.盘中异动 早盘股价大跌5.08%
自选股智能写手 · 07-24
Inmune Bio Inc.盘中异动 早盘股价大跌5.08%
Inmune Bio Inc.盘中异动 早盘快速拉升9.16%
自选股智能写手 · 07-22
Inmune Bio Inc.盘中异动 早盘快速拉升9.16%
Inmune Bio Inc.盘中异动 快速下挫5.07%
自选股智能写手 · 07-19
Inmune Bio Inc.盘中异动 快速下挫5.07%
Inmune Bio Inc.盘中异动 早盘快速跳水5.78%报9.29美元
自选股智能写手 · 07-17
Inmune Bio Inc.盘中异动 早盘快速跳水5.78%报9.29美元
Inmune Bio Inc.盘中异动 大幅上涨5.00%
自选股智能写手 · 07-10
Inmune Bio Inc.盘中异动 大幅上涨5.00%
Inmune Bio Inc.盘中异动 股价大跌5.11%
自选股智能写手 · 07-08
Inmune Bio Inc.盘中异动 股价大跌5.11%
Inmune Bio Inc.盘中异动 股价大涨6.72%报7.78美元
自选股智能写手 · 06-27
Inmune Bio Inc.盘中异动 股价大涨6.72%报7.78美元
Inmune Bio Inc.盘中异动 早盘股价大涨7.27%
自选股智能写手 · 06-26
Inmune Bio Inc.盘中异动 早盘股价大涨7.27%
Inmune Bio Inc.盘中异动 快速跳水5.01%报7.87美元
自选股智能写手 · 06-18
Inmune Bio Inc.盘中异动 快速跳水5.01%报7.87美元
公司概况
公司名称:
INmune Bio Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
INmune Bio Inc.最初于2015年9月25日在内华达州成立。公司的目标是开发和商业化他们的产品,治疗先天免疫系统无法正常工作或者由此导致的疾病。这些疾病包括癌症,其中NK细胞缺少活性导致肿瘤能逃避免疫系统,MDSC增殖以保护肿瘤免受患者免疫系统的攻击,也包括类似功能障碍或其他神经和代谢疾病的引起的慢性感染,慢性炎症引起免疫系统功能障碍进而导致的代谢疾病。INmune Bio Inc.最初的重点是治疗癌症 - 血液系统恶性肿瘤和实体瘤。
发行价格:
--
{"stockData":{"symbol":"INMB","market":"US","secType":"STK","nameCN":"INmune Bio Inc","latestPrice":6.95,"timestamp":1724443200000,"preClose":6.45,"halted":0,"volume":183930,"hourTrading":{"tag":"盘后","latestPrice":6.95,"preClose":6.95,"latestTime":"18:51 EDT","volume":2102,"amount":14609.65,"timestamp":1724453465896},"delay":0,"floatShares":13405300,"shares":19782429,"eps":-2.057766,"marketStatus":"休市中","marketStatusCode":7,"change":0.5,"latestTime":"08-23 16:00:00 EDT","open":6.47,"high":6.99,"low":6.42,"amount":1259223.4053,"amplitude":0.088372,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.057766,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1549256400000,"adjPreClose":6.45,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.46,"preClose":6.45,"latestTime":"09:28 EDT","volume":200,"amount":1292,"timestamp":1724419681771},"postHourTrading":{"tag":"盘后","latestPrice":6.95,"preClose":6.95,"latestTime":"18:51 EDT","volume":2102,"amount":14609.65,"timestamp":1724453465896},"volumeRatio":0.6620784823999752,"impliedVol":1.3266,"impliedVolPercentile":0.8929},"requestUrl":"/m/hq/s/INMB/wiki","defaultTab":"wiki","newsList":[{"id":"2461350088","title":"美国研究综述-阿迪生物科学公司、塔吉特公司、伟世通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2461350088","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461350088?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:07","pubTimestamp":1724310430,"startTime":"0","endTime":"0","summary":" 路透8月22日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Aadi Bioscience、Target 和伟世通。要闻 * Aadi Bioscience Inc :杰富瑞将其评级从 \"买入 \"下调至 \"持有 * 塔吉特公司 :杰富瑞将目标价从 190 美元上调至 195 美元 * 伟世通公司 :加拿大皇家银行将目标价从144美元下调至129美元以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTRE","LU0154245673.USD","ACDC","PTEN","M","LU0985489474.SGD","WOLF","HAL","S","LU1244550577.SGD","SNPS","IE00BLSP4239.USD","PDS","CHX","A","LU0823411888.USD","TS","TGT","TJX","IE0002270589.USD","AADI","BK4548","OKE","LU1951198990.SGD","ALHC","ALC","LU0878866978.SGD","TOL","COTY","URBN","INMB","WTTR","KLXE","WFRD","LU0251142724.SGD","VC","LU1951200564.SGD","LU1988902786.USD","RNGR","SGXZ23171101.USD","FTI","GTLS","SLB","DY","BKR","WHD","OIS"],"gpt_icon":1},{"id":"2461882597","title":"Inmune Bio Inc.盘中异动 快速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461882597","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461882597?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:03","pubTimestamp":1724173408,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时03分,Inmune Bio Inc.股票出现波动,股价大幅跳水5.29%。截至发稿,该股报6.62美元/股,成交量9.8378万股,换手率0.50%,振幅6.58%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408210103289719959a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408210103289719959a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2459210596","title":"Inmune Bio Inc.盘中异动 急速拉升5.09%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210596","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210596?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:05","pubTimestamp":1723817112,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时05分,Inmune Bio Inc.股票出现波动,股价快速上涨5.09%。截至发稿,该股报7.22美元/股,成交量2.7429万股,换手率0.14%,振幅4.66%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.涨幅较大,Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为4130.26%、1500.86%、171.21%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Seelos Therapeutics, Inc.,振幅分别为100.53%、41.25%、36.81%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081622051397198f72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081622051397198f72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007","INMB","BK4139"],"gpt_icon":1},{"id":"2459100593","title":"Inmune Bio Inc.盘中异动 快速下跌5.01%报6.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459100593","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459100593?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:59","pubTimestamp":1723654761,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时59分,Inmune Bio Inc.股票出现波动,股价急速下挫5.01%。截至发稿,该股报6.63美元/股,成交量8.6401万股,换手率0.44%,振幅5.73%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为0.34%。其相关个股中,Unicycive Therapeutics, Inc.、Zura Bio Limited C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm Plc较为活跃,换手率分别为92.33%、79.15%、70.00%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm Plc,振幅分别为60.83%、58.52%、49.86%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815005921a1d44a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815005921a1d44a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2458682382","title":"Inmune Bio Inc.2024财年第二财季实现净利润-9.75百万美元,同比减少50.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682382","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682382?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:16","pubTimestamp":1723306564,"startTime":"0","endTime":"0","summary":"8月11日,Inmune Bio Inc.公布财报,公告显示公司2024财年第二财季净利润为-9.75百万美元,同比减少50.00%;其中营业收入为0.00美元,每股基本收益为-0.50美元。从资产负债表来看,Inmune Bio Inc.总负债15.37百万美元,其中短期债务5.11百万美元,资产负债比为3.42,流动比率为2.36。机构评级:截至2024年8月11日,当前有3家机构对Inmune Bio Inc.目标价做出预测,其中目标均价为19.67美元,其中最低目标价为16.00美元,最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001615958e72c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001615958e72c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB"],"gpt_icon":0},{"id":"2458034988","title":"Inmune Bio Inc.盘中异动 临近午盘股价大涨5.11%报7.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458034988","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458034988?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:52","pubTimestamp":1723132368,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时52分,Inmune Bio Inc.股票出现波动,股价大幅拉升5.11%。截至发稿,该股报7.41美元/股,成交量3.6374万股,换手率0.18%,振幅6.38%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为3.09%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃,换手率分别为378.88%、288.60%、182.73%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.,振幅分别为103.39%、54.41%、45.58%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235248aefdf372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235248aefdf372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2457377840","title":"Inmune Bio Inc.盘中异动 早盘股价大跌7.59%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457377840","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457377840?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865126,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分,Inmune Bio Inc.股票出现波动,股价急速下挫7.59%。截至发稿,该股报7.55美元/股,成交量1.025万股,换手率0.05%,振幅1.35%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为1.94%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213846957f3285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213846957f3285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2456554233","title":"Inmune Bio Inc.盘中异动 早盘股价大涨5.18%报8.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456554233","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456554233?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:47","pubTimestamp":1722610028,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时47分,Inmune Bio Inc.股票出现波动,股价快速上涨5.18%。截至发稿,该股报8.32美元/股,成交量7.2981万股,换手率0.37%,振幅8.22%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为1.99%。其相关个股中,Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.涨幅较大,Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为4415.97%、642.83%、73.33%,振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为79.69%、64.24%、60.61%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802224708af95a8f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802224708af95a8f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2455916690","title":"INmune Bio Inc 预计每股亏损63美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455916690","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455916690?lang=zh_cn&edition=full","pubTime":"2024-07-31 07:43","pubTimestamp":1722383007,"startTime":"0","endTime":"0","summary":" * INmune Bio Inc 将于8月1日公布截至0001年1月1日的业绩报告,预计该公司的季度收入将出现下降。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于佛罗里达州博卡拉顿的公司的营收预计将从一年前的4.6万美元下降92.8%至3.33万美元。* LSEG 分析师对 INmune Bio Inc 的平均预期是每股亏损 63 美分。* 华尔街对 INmune Bio Inc 的 12 个月目标价中位数为 21.00 美元,高于其最新收盘价 8.26 美元。7月30日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB"],"gpt_icon":0},{"id":"2455495595","title":"Inmune Bio Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455495595","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455495595?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:24","pubTimestamp":1722349455,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日22时24分,Inmune Bio Inc.股票出现异动,股价大幅下跌5.03%。截至发稿,该股报7.93美元/股,成交量4.5783万股,换手率0.23%,振幅6.11%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.51%。其相关个股中,Imunon, Inc.、Processa Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Processa Pharmaceuticals, Inc.、Imunon, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1607.23%、967.07%、862.35%,振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为74.79%、52.35%、49.65%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730222415af94dd6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730222415af94dd6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2455650834","title":"INmune Bio Inc.宣布了新的第1阶段研究数据证明了Xpro™对调节阿尔茨海默病患者突触蛋白具有剂量依赖性影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455650834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455650834?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:00","pubTimestamp":1722258002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2453000233","title":"Inmune Bio Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453000233","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453000233?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:32","pubTimestamp":1721827938,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日21时32分,Inmune Bio Inc.股票出现波动,股价快速下挫5.08%。截至发稿,该股报8.03美元/股,成交量2546股,换手率0.01%,振幅2.84%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.涨幅较大,Dermata Therapeutics, Inc.、Azitra Inc、Hoth Therapeutics, Inc.较为活跃,换手率分别为3370.36%、846.10%、459.46%,振幅较大的相关个股有Sangamo Therapeutics, Inc.、Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.,振幅分别为43.66%、27.69%、14.66%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242132189ee65265&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242132189ee65265&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2453793847","title":"Inmune Bio Inc.盘中异动 早盘快速拉升9.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453793847","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453793847?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:30","pubTimestamp":1721655059,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时30分,Inmune Bio Inc.股票出现波动,股价大幅拉升9.16%。截至发稿,该股报8.82美元/股,成交量3389股,换手率0.02%,振幅0.00%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Mei Pharma, Inc.、Enveric Biosciences, Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为92.26%、76.81%、15.01%,振幅较大的相关个股有Exicure, Inc.、Barinthus Biotherapeutics Plc、Cg Oncology, Inc.,振幅分别为9.72%、4.29%、4.03%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213100af9371a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213100af9371a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2452374224","title":"Inmune Bio Inc.盘中异动 快速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452374224","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452374224?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:24","pubTimestamp":1721323496,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时24分,Inmune Bio Inc.股票出现波动,股价快速下跌5.07%。截至发稿,该股报8.62美元/股,成交量3.6556万股,换手率0.18%,振幅5.95%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为1.49%。其相关个股中,Onconetix, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silo Pharma, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃,换手率分别为2569.43%、2464.58%、1255.48%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190124569681e20a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190124569681e20a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2452163026","title":"Inmune Bio Inc.盘中异动 早盘快速跳水5.78%报9.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452163026","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452163026?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:49","pubTimestamp":1721227755,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时49分,Inmune Bio Inc.股票出现波动,股价快速跳水5.78%。截至发稿,该股报9.29美元/股,成交量1.6027万股,换手率0.08%,振幅4.56%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为1.69%。其相关个股中,Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aditxt, Inc.涨幅较大,Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃,换手率分别为2661.78%、1223.59%、263.03%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.,振幅分别为76.39%、43.75%、31.25%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172249169681db10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172249169681db10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2450816723","title":"Inmune Bio Inc.盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816723","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450816723?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:03","pubTimestamp":1720620194,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时03分,Inmune Bio Inc.股票出现波动,股价快速拉升5.00%。截至发稿,该股报8.19美元/股,成交量8396股,换手率0.04%,振幅5.13%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为2167.67%、1010.33%、621.61%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.,振幅分别为119.83%、62.50%、59.23%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102203149681b8d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102203149681b8d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4139","LGVN","INMB","BK4007"],"gpt_icon":0},{"id":"2449704244","title":"Inmune Bio Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449704244","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449704244?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:57","pubTimestamp":1720450655,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时57分,Inmune Bio Inc.股票出现异动,股价急速跳水5.11%。截至发稿,该股报7.43美元/股,成交量7.8572万股,换手率0.40%,振幅6.26%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708225735941f4f50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708225735941f4f50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","INMB","BK4007","BK4139"],"gpt_icon":0},{"id":"2446553780","title":"Inmune Bio Inc.盘中异动 股价大涨6.72%报7.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446553780","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446553780?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:32","pubTimestamp":1719495127,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时32分,Inmune Bio Inc.股票出现异动,股价大幅上涨6.72%。截至发稿,该股报7.78美元/股,成交量3034股,换手率0.02%,振幅0.96%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Nls Pharmaceutics Ltd.、Effector Therapeutics Inc C/Wts 31/12/2025 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Nls Pharmaceutics Ltd.、Gri Bio, Inc.、Kala Bio, Inc.较为活跃,换手率分别为148.61%、90.56%、58.21%,振幅较大的相关个股有Nls Pharmaceutics Ltd.、冠科美博、Engene Holdings Inc.,振幅分别为19.33%、12.57%、10.75%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721320796817814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721320796817814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2446395772","title":"Inmune Bio Inc.盘中异动 早盘股价大涨7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446395772","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446395772?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:31","pubTimestamp":1719408685,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时31分,Inmune Bio Inc.股票出现波动,股价急速拉升7.27%。截至发稿,该股报7.67美元/股,成交量3999股,换手率0.02%,振幅0.98%。Inmune Bio Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Savara, Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为275.35%、59.80%、58.02%,振幅较大的相关个股有Anew Medical, Inc.、Atossa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.,振幅分别为33.00%、20.87%、19.51%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621312596817137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621312596817137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2444439147","title":"Inmune Bio Inc.盘中异动 快速跳水5.01%报7.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444439147","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444439147?lang=zh_cn&edition=full","pubTime":"2024-06-18 22:22","pubTimestamp":1718720566,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日22时22分,Inmune Bio Inc.股票出现波动,股价大幅下挫5.01%。截至发稿,该股报7.87美元/股,成交量4.7158万股,换手率0.24%,振幅6.04%。Inmune Bio Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Inmune Bio Inc.公司简介:INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618222246aef57a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618222246aef57a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inmunebio.com","stockEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":-0.1586},{"period":"3month","weight":-0.3126},{"period":"6month","weight":-0.4621},{"period":"1year","weight":-0.1312},{"period":"ytd","weight":-0.3828}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"INmune Bio Inc.最初于2015年9月25日在内华达州成立。公司的目标是开发和商业化他们的产品,治疗先天免疫系统无法正常工作或者由此导致的疾病。这些疾病包括癌症,其中NK细胞缺少活性导致肿瘤能逃避免疫系统,MDSC增殖以保护肿瘤免受患者免疫系统的攻击,也包括类似功能障碍或其他神经和代谢疾病的引起的慢性感染,慢性炎症引起免疫系统功能障碍进而导致的代谢疾病。INmune Bio Inc.最初的重点是治疗癌症 - 血液系统恶性肿瘤和实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.062369},{"month":2,"riseRate":0.2,"avgChangeRate":-0.052369},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.147192},{"month":4,"riseRate":0.666667,"avgChangeRate":0.149477},{"month":5,"riseRate":0.5,"avgChangeRate":-0.001076},{"month":6,"riseRate":0.5,"avgChangeRate":0.096729},{"month":7,"riseRate":0.333333,"avgChangeRate":0.156708},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.036837},{"month":9,"riseRate":0,"avgChangeRate":-0.122393},{"month":10,"riseRate":0.4,"avgChangeRate":-0.03285},{"month":11,"riseRate":0.4,"avgChangeRate":0.015743},{"month":12,"riseRate":0.6,"avgChangeRate":0.200435}],"exchange":"NASDAQ","name":"INmune Bio Inc","nameEN":"INmune Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供INmune Bio Inc(INMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"INmune Bio Inc,INMB,INmune Bio Inc股票,INmune Bio Inc股票老虎,INmune Bio Inc股票老虎国际,INmune Bio Inc行情,INmune Bio Inc股票行情,INmune Bio Inc股价,INmune Bio Inc股市,INmune Bio Inc股票价格,INmune Bio Inc股票交易,INmune Bio Inc股票购买,INmune Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供INmune Bio Inc(INMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}